
(AGENPARL) – SILVER SPRING gio 16 marzo 2023 Patient input is a critical part of CBER’s understanding of diseases and conditions. Engaging with patients and listening to their perspectives on their diseases and treatments may help the center advance patient-focused medical product development.
Fonte/Source: http://www.fda.gov/vaccines-blood-biologics/development-approval-process-cber/center-biologics-evaluation-and-research-patient-engagement-program